NME2 and neuroblastoma: Concentration-dependent expression changes were confirmed by qRT-PCR for several N-Myc target genes including NME2, an inhibitor of differentiation located on a region of chromosome 17q that is prone to amplification in aggressive neuroblastomas [32,39].